DrugDashboards

Docetaxel

Docetaxel · DOCETAXEL ANHYDROUS 20 mg/mL · Injection, Solution · Intravenous · Sun Pharmaceutical Industries, Inc.

NDC 47335-0323-40 · 1 VIAL, GLASS in 1 CARTON / 1 mL in 1 VIAL, GLASS · NDA · View full market →

The short version

10 companies supply this market — deep enough that no single failure threatens the supply. One of its named manufacturing plants, Sun Pharmaceutical Industries Limited, failed FDA inspectionwithin the last two years — the agency’s most serious outcome.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$25.00
Reported to Texas DSHS · 2026 annual filing · Sun Pharma

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2023)

$20,864
11 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $480.15 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
NDA022534
TE code
—
Approval date
May 3, 2011
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Docetaxel (Injection, Solution)

LabelerStrengthFirst seenLast seen
Baxter Healthcare CorporationDOCETAXEL 10 mg/mLJul 15, 2026Sep 3, 2026
Dr. Reddy's Laboratories Inc.DOCETAXEL 20 mg/mLJul 15, 2026Sep 3, 2026
Dr. Reddy's Laboratories Inc.DOCETAXEL 80 mg/4mLJul 15, 2026Sep 3, 2026
Hospira, Inc.DOCETAXEL 20 mg/mLJul 15, 2026Sep 3, 2026
Zhuhai Beihai Biotech Co., Ltd.DOCETAXEL ANHYDROUS 20 mg/mLJul 15, 2026Sep 3, 2026
Zydus Pharmaceuticals USA Inc.DOCETAXEL ANHYDROUS 20 mg/mLJul 15, 2026Sep 3, 2026
Avyxa Pharma, LLCDOCETAXEL 20 mg/2mLJul 15, 2026Sep 2, 2026
Avyxa Pharma, LLCDOCETAXEL 80 mg/8mLJul 15, 2026Sep 2, 2026
Avyxa Pharma, LLCDOCETAXEL 160 mg/16mLJul 15, 2026Sep 2, 2026
Chongqing Sintaho Pharmaceutical Co., Ltd.DOCETAXEL 1 g/gJul 15, 2026Sep 2, 2026
Dr. Reddy's Laboratories Inc.DOCETAXEL 160 mg/8mLJul 15, 2026Sep 2, 2026
Sandoz Inc.DOCETAXEL 10 mg/mLJul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.DOCETAXEL ANHYDROUS 160 mg/8mLJul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.DOCETAXEL ANHYDROUS 20 mg/mLJul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.DOCETAXEL ANHYDROUS 80 mg/4mLJul 15, 2026Sep 2, 2026
Eugia US LLCDOCETAXEL ANHYDROUS 10 mg/mLJul 15, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Docetaxel — NDC 47335-0323-40," retrieved September 3, 2026, https://drugdashboards.com/drug/47335032340.

Free to cite with attribution — see how the data is put together.